Bjørn Dahl

Mansathali Intervenes to Rescue Child from Social Media Addiction

2 min read

Mansathali Intervenes to Rescue Child from Social Media Addiction

Today, the whole world is dominated by digital technology; it doesn’t matter what your age or gender...

Read More

CMUH (Taiwan) Launches “Intelligent Sepsis Early Prediction System (ISEPS),” Detecting Sepsis in One Minute Only

1 min read

CMUH (Taiwan) Launches “Intelligent Sepsis Early Prediction System (ISEPS),” Detecting Sepsis in One Minute Only

In conventional practice, a blood culture report wouldn’t be available until 18 to 72 hours later, rendering...

Read More

ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024 

5 min read

ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024 

ZEISS Medical Technology will showcase the latest in 3D visualization technology and surgical innovation at the American Society...

Read More

Venus Remedies gets huge global acclaim with UNICEF GMP approval

2 min read

Venus Remedies gets huge global acclaim with UNICEF GMP approval

Venus Remedies Limited, a leading global pharmaceutical company, has recently secured Good Manufacturing Practices (GMP) approval from...

Read More

Philip Morris To Open New Cigarette Factory in Tanzania, Showing It Isn’t Serious About Creating a “Smoke-Free Future”

2 min read

Philip Morris To Open New Cigarette Factory in Tanzania, Showing It Isn’t Serious About Creating a “Smoke-Free Future”

Philip Morris International, the world’s largest publicly traded cigarette company, plans to open a new cigarette factory...

Read More

Ultimovacs announces publication of results from NIPU Phase II trial with UV1 vaccination in mesothelioma in European Journal of Cancer

1 min read

Ultimovacs announces publication of results from NIPU Phase II trial with UV1 vaccination in mesothelioma in European Journal of Cancer

Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announced that the...

Read More

Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers

2 min read

Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a pipeline of development...

Read More

Servier Receives Regulatory Filing Acceptances from FDA and EMA for Vorasidenib in the Treatment of IDH-Mutant Diffuse Glioma

4 min read

Servier Receives Regulatory Filing Acceptances from FDA and EMA for Vorasidenib in the Treatment of IDH-Mutant Diffuse Glioma

Servier, a global leader in oncology focused on delivering meaningful therapeutic progress for the patients it serves,...

Read More

SIBIONICS Announces Participation in the 17th International Conference on Advanced Technologies and Treatments for Diabetes

2 min read

SIBIONICS Announces Participation in the 17th International Conference on Advanced Technologies and Treatments for Diabetes

SIBIONICS, the world’s third-largest continuous glucose monitoring (CGM) brand, announced that it will participate in the International...

Read More

United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease

2 min read

United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the...

Read More